|
Session 145
Poster Abstracts
Morbidity and Mortality from Hepatitis C in the HIV-Infected Population
Wednesday, 1:30 - 3:30 pm
Poster Hall |
865
 |
Hepatitis C Virus Co-infection Is Associated with Higher Risk of Death Due to HIV and Liver-related Disease among an HIV-infected Cohort
John Scott*, A Wald, M Kitahata, S Van Rompaey, E Krantz, A Meier, L Drolette, L Corey, and C Wang
Univ of Washington, Seattle, US |
| 866 |
Predictors of Mortality in HCV and HCV/HIV-co-infected Persons on Dialysis
Adeel Butt*1,2,3, R Evans1, M Skanderson2, and A Shakil1
1Univ of Pittsburgh, PA, US; 2VA Pittsburgh Hlthcare System, PA, US; and 3Ctr for Hlth Equity Res and Promotion, Pittsburgh, PA, US |
| 867 |
Prediction of Significant Hepatic Fibrosis in HIV/HCV-co-infected Patients: Comparison of the FIB-4, APRI and Johns Hopkins Fibrosis Index
Mark S. Sulkowski*, S Mehta, M Torbenson, S Brinkley, R Montes De Oca, R Moore, and D Thomas
Johns Hopkins Univ, Baltimore, MD, US |
| 868 |
Predictors of Liver Fibrosis in HIV-infected Patients with Chronic Hepatitis C
Pablo Barreiro*, L Martín-Carbonero, M Nuñez, P Rivas, N Simarro, J González-Lahoz, and V Soriano
Hosp Carlos III, Madrid, Spain |
| 869 |
Contribution of Drug Use and Lifestyle to Hepatic Fibrosis in HIV/HCV Co-infection
Huda Al-Morhi*1, T Murphy1, A Balaster1, C Kato1, D Rouleau2, J Cox1, and M Klein1
1McGill Univ Hlth Ctr, Montreal, Canada and 2Ctr Hosp Univ Montreal, Canada |
870
|
Influence of Hepatitis C Virus Infection on Mitochondrial DNA Depletion in HIV-co-infected Patients
Carmen De Mendoza*1, N Zahonero1, P Barreiro1, M De Baar2, L Capa1, J Benito1, and V Soriano1
1Hosp Carlos III, Madrid, Spain and 2Primagen, Amsterdam, The Netherlands |
| 871 |
Fatty Liver Disease Is no more Frequent in HIV-infected Individuals Co-infected with HCV or HBV than in the HIV-mono-infected Population
M Ristig1, Pablo Tebas*1, J Aberg2, E Overton3, H Wang3, J Crippin3, W Seyfried3, W Powderly4, and M Lisker-Melman3
1Univ of Pennsylvania, Philadelphia, US; 2New York Univ, NY, US; 3Washington Univ, St Louis, MO, US; and 4Univ Coll Dublin, Ireland |
872
|
Hepatic Steatosis in HIV/HCV-co-infected Patients Receiving ART
Valerie Martinez*, N Ta, Z Mokhtari, M A Valantin, F Charlotte, R Agher, Y Benhamou, E Caumes, C Katlama, and F Bricaire
Hosp Pitié-Salpétrière, Paris, France |
| 873 |
Hierarchy of Liver-related Major Complications in a Cohort of Co-infected Patients with Compensated Liver Cirrhosis
Raffaele Bruno*, P Sacchi, S Patruno, L Maiocchi, and G Filice
IRCCS San Matteo, Univ of Pavia, Italy |
| 874 |
Liver Transplantation in HIV-co-infected Patients Treated by Enfuvirtide
Elina Teicher*1, D Vittecoq1, A M Taburet2, L Bonhomme Faivre1, E Dussaix1, D Castaing1, J C Duclos-Vallée1, and D Samuel1
1Paul Brousse Hosp, Villejuif, France and 2Kremlin Bicetre Hosp, France |
| 875 |
Orthotopic Liver Transplantation in HIV-1-infected Patients in Spain: A Prospective Cohort Study of 50 Cases
José M Miró*1, M Montejo2, V Vargas3, A Rimola1, A Rafecas4, P Miralles5, J Fortún6, M Blanes7, J Torre-Cisneros8, J Pons9, and the Spanish OLT in HIV-Infected Patients Study Group
1Hosp Clin, Univ of Barcelona, Spain; 2Hosp de Cruces, Bilbao, Spain; 3Hosp Univ Vall d’Hebrón, Barcelona, Spain; 4Hosp Univ Bellvitge, Barcelona, Spain; 5Hosp Gen Univ Gregorio Marañón, Madrid, Spain; 6Hosp Ramón y Cajal, Madrid, Spain; 7Hosp La Fé, Valencia, Spain; 8Hosp Univ Reina Sofía, Córdoba, Spain; and 9Hosp Univ Virgen de la Arrixaca, Murcia, Spain |
876
|
Mortality in Siblings of Patients Co-infected with HIV and Hepatitis C
Ann-Brit Eg Hansen*1, J Gerstoft2, G Kronborg3, H Sørensen4,5, and N Obel1
1Odense Univ Hosp and Univ of Southern Denmark; 2Copenhagen University Hosp, Rigshospitalet, Copenhagen, Denmark; 3Hvidovre Univ Hosp, Denmark; 4Aarhus Univ Hosp, Denmark; and 5Boston Univ Sch of Publ Hlth, MA, US |
| 877 |
Influence of Hepatitis C Genotypes on Lipid Elevations in HIV+ Patients during HAART
G Lapadula1, Carlo Torti*1, G Cologni1, F Castelnuovo2, F Moretti1, S Costarelli1, N Ladisa3, R Maserati3, M Di Pietro4, G Carosi1, and EPOKa-A Study Group of the MASTER Cohort
1Univ of Brescia, Italy; 2Hosp Civili, Brescia, Italy; 3IRCCS Policlin San Matteo, Pavia, Italy; and 4Hosp SM Annunziata, Firenze, Italy |
878
|
Hepatitis C Infection Is Associated with Decreased Use of Lipid-lowering Therapy 48 Weeks after Initiation of Combination ART in the ACTG 5001: ALLRT Cohort
Jack T Stapleton*1, K Bennett2, R Bosch2, P Polgreen1, and S Swindells3
1VAMC and Univ of Iowa, Iowa City, US; 2Statistical and Data Analysis Ctr, Harvard Sch of Publ Hlth, Boston, MA, US; and 3Univ of Nebraska Med Ctr, Omaha, US |
879
|
Hepatitis C/HIV-1-co-infection in Long-term Non-progressors
Pedro Castro*, M Laguno, F García, M Plana, E Fumero, M Nomdedeu, T Gallart, J Mallolas, J Miró, and J Gatell
Hosp Clin, Univ of Barcelona, Spain |
|
